Developed by Gnosis, ibSium® is a patented probiotic yeast registered as Saccharomyces cerevisiae CNCM I-3856. Recognized as a reference probiotic strain, ibSium® has demonstrated its effectiveness in several rigorous clinical studies, showing that this yeast can significantly relieve gastrointestinal symptoms and improve overall quality of life.
Moreover, a recent independent meta-analysis by renowned gastroenterologists further highlights ibSium® as the only probiotic strain significantly reducing abdominal pain.
During SSW, we had great interest in this innovative probiotic yeast for its robust scientific support and its unique advantages as a yeast. Saccharomyces cerevisiae CNCM I-3856 has anti-pathogenic effects in the gut without permanently colonizing the microbiome. Additionally, this natural yeast is compatible with antibiotic treatments, offering a safe and versatile option for digestive support.
We also won an award for MenaQ7® Matrix in the joint health category.
MenaQ7® Matrix, our proprietary Vitamin K2 solution, earned top recognition for supporting cardiovascular and bone health. This advanced technology empowers manufacturers to create complex, innovative formulations, opening new opportunities for using vitamin K2 in supplements.
We are proud to drive advancements in health and wellness with science-based, impactful solutions!
Do you need more information about our solutions or have any outstanding questions? Please do not hesitate to contact us; our expert team will be happy to answer!
Latest News
- Digestion & Gut
- ibSium®
- News
- May 29, 2025
Natural Probiotic Yeast Support on World Digestive Health Day
Each year on May 29, World Digestive Health Day raises global awareness about the...
- Lynside® Nutritional Yeasts
- News
- Wellness & Immune
- May 27, 2025
Infodemiology Offers a Fresh Lens on Nutritional Yeast
Haven’t you ever wondered what consumers think about yeast? Infodemiology, an innovative social media...
- MenaQ7®
- Mobility & Joint
- News
- May 21, 2025
K2SAC’s 4th Meeting Showcases New Clinical Insights and Emerging Talent in Vitamin K2 Research
On May 12-13, the 4th Gnosis Vitamin K2 Scientific Advisory Committee meeting convened leading...
